- Home
- NRDY vs ZURA Comparison
NRDY vs ZURA Comparison
Compare NRDY & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDY
- ZURA
- Stock Information
- Founded
- NRDY 2007
- ZURA 2022
- Country
- NRDY United States
- ZURA United States
- Employees
- NRDY N/A
- ZURA N/A
- Industry
- NRDY Computer Software: Prepackaged Software
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NRDY Technology
- ZURA Health Care
- Exchange
- NRDY Nasdaq
- ZURA Nasdaq
- Market Cap
- NRDY 155.4M
- ZURA 137.2M
- IPO Year
- NRDY N/A
- ZURA N/A
- Fundamental
- Price
- NRDY $1.25
- ZURA $4.34
- Analyst Decision
- NRDY Hold
- ZURA Buy
- Analyst Count
- NRDY 7
- ZURA 9
- Target Price
- NRDY $1.60
- ZURA $11.00
- AVG Volume (30 Days)
- NRDY 487.2K
- ZURA 4.0M
- Earning Date
- NRDY 11-06-2025
- ZURA 11-06-2025
- Dividend Yield
- NRDY N/A
- ZURA N/A
- EPS Growth
- NRDY N/A
- ZURA N/A
- EPS
- NRDY N/A
- ZURA N/A
- Revenue
- NRDY $178,378,000.00
- ZURA N/A
- Revenue This Year
- NRDY $3.34
- ZURA N/A
- Revenue Next Year
- NRDY $10.69
- ZURA N/A
- P/E Ratio
- NRDY N/A
- ZURA N/A
- Revenue Growth
- NRDY N/A
- ZURA N/A
- 52 Week Low
- NRDY $0.75
- ZURA $0.97
- 52 Week High
- NRDY $2.18
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- NRDY 38.94
- ZURA 79.95
- Support Level
- NRDY $1.20
- ZURA $2.07
- Resistance Level
- NRDY $1.29
- ZURA $4.28
- Average True Range (ATR)
- NRDY 0.06
- ZURA 0.21
- MACD
- NRDY -0.01
- ZURA 0.22
- Stochastic Oscillator
- NRDY 15.30
- ZURA 89.42
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.